Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism
Yang, Wei1; Bai, Yibing1; Xiong, Ying2; Zhang, Jin1; Chen, Shuokai1; Zheng, Xiaojun3; Meng, Xiangbo1; Li, Lunyi1; Wang, Jing4; Xu, Chenguang4; Yan, Chengsong1; Wang, Lijuan2; Chang, Catharine C. Y.5; Chang, Ta-Yuan5; Zhang, Ti6; Zhou, Penghui7; Song, Bao-Liang8; Liu, Wanli4; Sun, Shao-Cong9; Liu, Xiaolong10; Li, Bo-liang2; Xu, Chenqi1,11
2016-03-31
Source PublicationNATURE
ISSN0028-0836
Volume531Issue:7596Pages:651-+
Status已发表
DOI10.1038/nature17412
AbstractCD8(+) T cells have a central role in antitumour immunity, but their activity is suppressed in the tumour microenvironment(1-4). Reactivating the cytotoxicity of CD8(+) T cells is of great clinical interest in cancer immunotherapy. Here we report a new mechanism by which the antitumour response of mouse CD8(+) T cells can be potentiated by modulating cholesterol metabolism. Inhibiting cholesterol esterification in T cells by genetic ablation or pharmacological inhibition of ACAT1, a key cholesterol esterification enzyme(5), led to potentiated effector function and enhanced proliferation of CD8(+) but not CD4(+) T cells. This is due to the increase in the plasma membrane cholesterol level of CD8(+) T cells, which causes enhanced T-cell receptor clustering and signalling as well as more efficient formation of the immunological synapse. ACAT1-deficient CD8(+) T cells were better than wildtype CD8(+) T cells at controlling melanoma growth and metastasis in mice. We used the ACAT inhibitor avasimibe, which was previously tested in clinical trials for treating atherosclerosis and showed a good human safety profile(6,7), to treat melanoma in mice and observed a good antitumour effect. A combined therapy of avasimibe plus an anti-PD-1 antibody showed better efficacy than monotherapies in controlling tumour progression. ACAT1, an established target for atherosclerosis, is therefore also a potential target for cancer immunotherapy.
Indexed BySCI
Language英语
Funding ProjectMOST[2011CB910901] ; MOST[2012CB910804]
WOS Research AreaScience & Technology - Other Topics
WOS SubjectMultidisciplinary Sciences
WOS IDWOS:000373027400041
PublisherNATURE PUBLISHING GROUP
WOS KeywordTHYMOCYTE POSITIVE SELECTION ; CANCER-IMMUNOTHERAPY ; ACYL-COENZYME ; IMMUNOLOGICAL SYNAPSE ; IMMUNE MODULATION ; MEMBRANE-BINDING ; ACAT INHIBITORS ; RECEPTOR ; ACTIVATION ; DOMAIN
Original Document TypeArticle
Citation statistics
Cited Times:264[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttps://kms.shanghaitech.edu.cn/handle/2MSLDSTB/1891
Collection生命科学与技术学院_特聘教授组_许琛琦组
Corresponding AuthorLi, Bo-liang; Xu, Chenqi
Affiliation1.Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai Sci Res Ctr,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
4.Tsinghua Univ, Collaborat Innovat Ctr Infect Dis, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China
5.Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH USA
6.Second Mil Med Univ, ChangZheng Hosp, Rheumatol & Immunol Dept, Shanghai 200433, Peoples R China
7.Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
8.Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei Province, Peoples R China
9.Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA
10.Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China
11.ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China
Corresponding Author AffilicationSchool of Life Science and Technology
Recommended Citation
GB/T 7714
Yang, Wei,Bai, Yibing,Xiong, Ying,et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism[J]. NATURE,2016,531(7596):651-+.
APA Yang, Wei.,Bai, Yibing.,Xiong, Ying.,Zhang, Jin.,Chen, Shuokai.,...&Xu, Chenqi.(2016).Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism.NATURE,531(7596),651-+.
MLA Yang, Wei,et al."Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism".NATURE 531.7596(2016):651-+.
Files in This Item: Download All
File Name/Size DocType Version Access License
10.1038@nature17412.(4164KB)期刊论文作者接受稿开放获取UnknownView Download
Related Services
Usage statistics
Scholar Google
Similar articles in Scholar Google
[Yang, Wei]'s Articles
[Bai, Yibing]'s Articles
[Xiong, Ying]'s Articles
Baidu academic
Similar articles in Baidu academic
[Yang, Wei]'s Articles
[Bai, Yibing]'s Articles
[Xiong, Ying]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Yang, Wei]'s Articles
[Bai, Yibing]'s Articles
[Xiong, Ying]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: 10.1038@nature17412.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.